Novocure's $27,760 device (Optune) is highly unaffordable for cancer patients
Register to read the full analysis —or— Upgrade to access more features
#price
#cancer
#affordability
#affordablehealth
Actual Direct Impact
Share this Analysis
Keen to rectify an issue with this analysis?
Report issue
There is no comments.